Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prediction of pH-Dependent Drug-Drug Interactions for Basic Drugs Using Physiologically Based Biopharmaceutics Modeling: Industry Case Studies
Amitava Mitra, Neil Parrott, Neil A. Miller, et al.
Journal of Pharmaceutical Sciences (2019) Vol. 109, Iss. 3, pp. 1380-1394
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network
Zahari Vinarov, Bertil Abrahamsson, Per Artursson, et al.
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 289-331
Open Access | Times Cited: 114
Crosstalk of physiological pH and chemical pKa under the umbrella of physiologically based pharmacokinetic modeling of drug absorption, distribution, metabolism, excretion, and toxicity
Lu Gaohua, Xiu‐Sheng Miao, Dou Liu
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 9, pp. 1103-1124
Open Access | Times Cited: 106
Applications, Challenges, and Outlook for PBPK Modeling and Simulation: A Regulatory, Industrial and Academic Perspective
Wen Lin, Yuan Chen, Jashvant D. Unadkat, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 8, pp. 1701-1731
Closed Access | Times Cited: 96
The therapeutic importance of acid-base balance
Bianca N. Quade, Mark D. Parker, Rossana Occhipinti
Biochemical Pharmacology (2020) Vol. 183, pp. 114278-114278
Open Access | Times Cited: 72
Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib
Stefanie L. Groenland, Alejandra Martínez-Chávez, Marloes G. J. van Dongen, et al.
Clinical Pharmacokinetics (2020) Vol. 59, Iss. 12, pp. 1501-1520
Closed Access | Times Cited: 71
Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development
Yurong Lai, Xiaoyan Chu, Li Di, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 6, pp. 2751-2777
Open Access | Times Cited: 58
Utility of PBPK Modeling in Predicting and Characterizing Clinical Drug Interactions
R. Foti
Drug Metabolism and Disposition (2024) Vol. 53, Iss. 1, pp. 100021-100021
Open Access | Times Cited: 9
Evaluation of Solubility-Limited Absorption as a Surrogate to Predicting Positive Food Effect of BCS II/IV Drugs
Karine Rodríguez-Fernández, José David Gómez‐Mantilla, Suneet Shukla, et al.
Clinical Pharmacokinetics (2025)
Open Access | Times Cited: 1
Current State and Future Expectations of Translational Modeling Strategies to Support Drug Product Development, Manufacturing Changes and Controls: A Workshop Summary Report
Xavier Pépin, Neil Parrott, Jennifer B. Dressman, et al.
Journal of Pharmaceutical Sciences (2020) Vol. 110, Iss. 2, pp. 555-566
Closed Access | Times Cited: 50
Biopharmaceutics Applications of Physiologically Based Pharmacokinetic Absorption Modeling and Simulation in Regulatory Submissions to the U.S. Food and Drug Administration for New Drugs
Fang Wu, Heta Shah, Min Li, et al.
The AAPS Journal (2021) Vol. 23, Iss. 2
Closed Access | Times Cited: 50
The Use of Physiologically Based Pharmacokinetic Analyses—in Biopharmaceutics Applications -Regulatory and Industry Perspectives
Om Anand, Xavier Pépin, Vidula Kolhatkar, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 8, pp. 1681-1700
Closed Access | Times Cited: 33
Physiologically Based Absorption Modelling to Explore the Impact of Food and Gastric pH Changes on the Pharmacokinetics of Entrectinib
Neil Parrott, Cordula Stillhart, Marc Lindenberg, et al.
The AAPS Journal (2020) Vol. 22, Iss. 4
Open Access | Times Cited: 42
Current State and Challenges of Physiologically Based Biopharmaceutics Modeling (PBBM) in Oral Drug Product Development
Di Wu, Min Li
Pharmaceutical Research (2022) Vol. 40, Iss. 2, pp. 321-336
Closed Access | Times Cited: 27
Assessing and mitigating pH-mediated DDI risks in drug development – formulation approaches and clinical considerations
Di Wu, Jiaying Liu, Erickson M. Paragas, et al.
Drug Metabolism Reviews (2024), pp. 1-20
Closed Access | Times Cited: 5
Physiologically based biopharmaceutics modeling of regional and colon absorption in humans
Christer Tannergren, Harshad Jadhav, Emma Eckernäs, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 186, pp. 144-159
Open Access | Times Cited: 11
Challenges in Predicting Colonic Luminal and Tissue Concentrations of Mesalamine and Acetyl Mesalamine Using Physiologically Based Biopharmaceutics Modeling
Harshad Jadhav, Arno Van Camp, Christer Tannergren, et al.
(2025)
Closed Access
Challenges in predicting colonic luminal and tissue concentrations of mesalamine and acetyl mesalamine using physiologically based biopharmaceutics modeling
Harshad Jadhav, Arno Van Camp, Christer Tannergren, et al.
International Journal of Pharmaceutics (2025), pp. 125547-125547
Closed Access
Bottom-Up Physiologically Based Oral Absorption Modeling of Free Weak Base Drugs
Naoya Matsumura, Asami Ono, Yoshiyuki Akiyama, et al.
Pharmaceutics (2020) Vol. 12, Iss. 9, pp. 844-844
Open Access | Times Cited: 24
Prediction of fasted and fed bioequivalence for immediate release drug products using physiologically based biopharmaceutics modeling (PBBM)
Rebeka Jereb, Albin Kristl, Amitava Mitra
European Journal of Pharmaceutical Sciences (2020) Vol. 155, pp. 105554-105554
Closed Access | Times Cited: 24
Integration of advanced methods and models to study drug absorption and related processes: An UNGAP perspective
Clive Wilson, Leon Aarons, Patrick Augustijns, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 172, pp. 106100-106100
Open Access | Times Cited: 21
Can PBPK Modeling Streamline Food Effect Assessments?
Filippos Kesisoglou
The Journal of Clinical Pharmacology (2020) Vol. 60, Iss. S1
Closed Access | Times Cited: 21
Towards Virtual Bioequivalence Studies for Oral Dosage Forms Containing Poorly Water-Soluble Drugs: A Physiologically Based Biopharmaceutics Modeling (PBBM) Approach
Atsushi Kambayashi, Jennifer B. Dressman
Journal of Pharmaceutical Sciences (2021) Vol. 111, Iss. 1, pp. 135-145
Open Access | Times Cited: 18
Acalabrutinib Maleate Tablets: The Physiologically Based Biopharmaceutics Model behind the Drug Product Dissolution Specification
Xavier Pépin, Vivien McAlpine, Andrea Moir, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 4, pp. 2181-2193
Closed Access | Times Cited: 7
The Use of Global Sensitivity Analysis to Assess the Oral Absorption of Weakly Basic Compounds: A Case Example of Dipyridamole
Siddharth S. Kesharwani, Guillaume Louit, Fady Ibrahim
Pharmaceutical Research (2024) Vol. 41, Iss. 5, pp. 877-890
Closed Access | Times Cited: 2
Physiologically Based Pharmacokinetic Modeling of Oral Absorption, pH, and Food Effect in Healthy Volunteers to Drive Alpelisib Formulation Selection
M Gajewska, Lars Blumenstein, Alexandros Kourentas, et al.
The AAPS Journal (2020) Vol. 22, Iss. 6
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top